Online education and training provided through programs, modules, and presentations

The Latest

In this month’s “Hot Topic,” Julia Lehman, M.D., will discuss a rare and potentially fatal mucocutaneous blistering disease that is often associated with an underlying malignancy, called paraneoplastic pemphigus. She will also discuss the specialized tissue and serum testing that is required to establish the diagnosis.
By MCL Education • April 8, 2019
PACE / State of CA / State of FL
In this "Phlebotomy Module," learners will be introduced to medical terminology, learning many of the terms they are likely to encounter in a health care setting. Additionally, information related to collection devices, types of equipment, and the situations to use them in will be discussed.
By MCL Education • April 1, 2019
In this month’s “Hot Topic,” Rajiv Pruthi, M.B.B.S., will discuss different types of hemophilia along with their pathologic basis. He will also cover various types of factor assays such as one stage and chromogenic factor assays for diagnosis and their role in management of hemophilia.
By MCL Education • March 28, 2019
PACE / State of CA / State of FL
In this month’s “Virtual Lecture,” Justin Kreuter, M.D., goes over the importance of maintaining a healthy blood donor community by talking about the effects of blood donation on stored iron and describes which individuals are at a higher risk for iron deficiency anemia.
By MCL Education • March 14, 2019
PACE / State of CA / State of FL
This month’s “Virtual Lecture” focuses on special considerations in the use of DOACs. Ariela Marshall, M.D., will discuss treatment of cancer-associated venous thromboembolism (VTE) and the outcomes of DOACs, as well as DOAC and antiphospholipid syndrome (APS) and heparin-induced thrombocytopenia (HIT). Then, Waldemar Wysokinski, M.D., Ph.D., will discuss the reversal of DOACs and outcomes.
By MCL Education • February 20, 2019
In this month’s “Hot Topic,” Brad Karon, M.D., Ph.D., will cover the need and evidence behind following the order of draw recommendations for routine blood collection. Specifically, does evidence demonstrate a need to collect serum tubes before either potassium EDTA or citrate tubes?
By Brad Karon, M.D., Ph.D. • February 12, 2019
PACE / State of CA / State of FL
In this month’s “Virtual Lecture,” Katherine Geiersbach, M.D., and Ruifeng (Ray) Guo, M.D., Ph.D., will describe currently available testing offered in Mayo Clinic’s Genomics Laboratory and review the genetics of malignant progression in melanocytic lesions.
By MCL Education • January 22, 2019
In this month’s “Hot Topic,” Robin Patel, M.D., discusses how matrix-assisted laser desorption ionization time of flight (MALDI TOF) mass spectrometry works for bacterial identification, including the strengths and limitations of this technology. She also covers Mayo Clinic’s experience with the technology in the clinical laboratory.
By Robin Patel, M.D. • January 15, 2019